Antoine Rimbert
Overview
Explore the profile of Antoine Rimbert including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
262
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Le May C, Ducheix S, Cariou B, Rimbert A
Curr Atheroscler Rep
. 2025 Jan;
27(1):26.
PMID: 39798054
Purpose Of Review: While lipid-lowering therapies demonstrate efficacy, many patients still contend with significant residual risk of atherosclerotic cardiovascular diseases (ASCVD). The intestine plays a pivotal role in regulating circulating...
2.
Ansari A, Yadav P, Zhou L, Prakash B, Ijaz L, Christiano A, et al.
JCI Insight
. 2025 Jan;
10(1).
PMID: 39782688
High apolipoprotein B-containing (apoB-containing) low-density lipoproteins (LDLs) and low apoA1-containing high-density lipoproteins (HDLs) are associated with atherosclerotic cardiovascular diseases. In search of a molecular regulator that could simultaneously and reciprocally...
3.
Bird M, Rimbert A, Pittman A, Humphries S, Futema M
Eur J Prev Cardiol
. 2024 Nov;
PMID: 39531635
Background: Familial Hypercholesterolaemia (FH) is an inherited disease of high LDL-cholesterol (LDL-C) caused by defects in LDLR, APOB, APOE and PCSK9 genes. A pathogenic variant cannot be found in ∼60%...
4.
Rimbert A, Duval D, Trujillano D, Kyndt F, Jobbe-Duval A, Lindenbaum P, et al.
medRxiv
. 2024 Nov;
PMID: 39484266
Background: Isolated posterior leaflet mitral valve prolapse (PostMVP), a common form of MVP, often referred as fibroelastic deficiency, is considered a degenerative disease. PostMVP patients are usually asymptomatic and often...
5.
Ansari A, Yadav P, Valmiki S, Laine A, Rimbert A, Islam S, et al.
J Lipid Res
. 2024 Sep;
65(10):100659.
PMID: 39332527
Plasma lipids are mainly carried in apolipoprotein B (apoB) containing lipoproteins. High levels of these lipoproteins are associated with several metabolic diseases and lowering their plasma levels is associated with...
6.
Rimbert A, Wargny M, Cariou B
J Hepatol
. 2024 Sep;
82(1):e50-e51.
PMID: 39299457
No abstract available.
7.
Michenaud L, Marrie N, Rimbert A, Marmontel O, Charriere S, Gibert C, et al.
Clin Chem Lab Med
. 2024 Jul;
PMID: 39069817
Objectives: Dysbetalipoproteinemia (DBL) is a combined dyslipidemia associated with an increased risk of atherosclerotic cardiovascular diseases mostly occurring in ε2ε2 subjects and infrequently in subjects with rare variants. Several algorithms...
8.
Roudaut M, Caillaud A, Souguir Z, Bray L, Girardeau A, Rimbert A, et al.
Bioeng Transl Med
. 2024 Jul;
9(4):e10659.
PMID: 39036087
The liver plays a key role in the metabolism of lipoproteins, controlling both production and catabolism. To accelerate the development of new lipid-lowering therapies in humans, it is essential to...
9.
Barkas F, Sener Y, Golforoush P, Kheirkhah A, Rodriguez-Sanchez E, Novak J, et al.
Atherosclerosis
. 2024 Jun;
395:117579.
PMID: 38824844
Atherosclerotic cardiovascular disease (ASCVD) remains a leading cause of morbidity and mortality worldwide, highlighting the urgent need for advancements in risk assessment and management strategies. Although significant progress has been...
10.
Ge X, Slutter B, Lambooij J, Zhou E, Ying Z, Agirman C, et al.
iScience
. 2024 May;
27(6):109830.
PMID: 38770137
The liver X receptor (LXR) is considered a therapeutic target for atherosclerosis treatment, but synthetic LXR agonists generally also cause hepatic steatosis and hypertriglyceridemia. Desmosterol, a final intermediate in cholesterol...